S&P 500   3,925.43
DOW   31,961.86
QQQ   324.13
S&P 500   3,925.43
DOW   31,961.86
QQQ   324.13
S&P 500   3,925.43
DOW   31,961.86
QQQ   324.13
S&P 500   3,925.43
DOW   31,961.86
QQQ   324.13
Log in

Pacific Biosciences of California Earnings Date, Estimates & History

-1.37 (-3.69 %)
(As of 02/24/2021 12:00 AM ET)
Today's Range
Now: $35.75
50-Day Range
MA: $38.26
52-Week Range
Now: $35.75
Volume5.64 million shs
Average Volume5.36 million shs
Market Capitalization$6.44 billion
P/E RatioN/A
Dividend YieldN/A


Pacific Biosciences of California (NASDAQ:PACB) Earnings Information

Pacific Biosciences of California last released its quarterly earnings data on February 9th, 2021. The biotechnology company reported $0.37 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.43 by $0.06. The firm earned $27.10 million during the quarter, compared to the consensus estimate of $25.54 million. Its quarterly revenue was up 41.9% on a year-over-year basis. Pacific Biosciences of California has generated ($0.55) earnings per share over the last year. Pacific Biosciences of California has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 5th, 2021 based off prior year's report dates.

Pacific Biosciences of California Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Pacific Biosciences of California (NASDAQ:PACB) Earnings Estimates

2021 EPS Consensus Estimate: ($0.66)
2022 EPS Consensus Estimate: ($0.61)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20212($0.44)($0.11)($0.28)
Q2 20212($0.18)($0.09)($0.14)
Q3 20212($0.17)($0.09)($0.13)
Q4 20212($0.17)($0.06)($0.12)
Q1 20221($0.17)($0.17)($0.17)
Q2 20221($0.16)($0.16)($0.16)
Q3 20221($0.15)($0.15)($0.15)
Q4 20221($0.13)($0.13)($0.13)

Pacific Biosciences of California (NASDAQ PACB) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
2/9/202112/31/2020$0.43$0.37($0.39)$25.54 million$27.10 millionTranscript
11/7/20209/30/2020($0.13)($0.14)($0.14)$20.40 million$19.08 millionTranscript
8/3/2020Q2 2020($0.19)($0.15)($0.15)$13.84 million$17.08 millionTranscript
5/6/20203/31/2020($0.16)($0.21)($0.33)$20.10 million$15.60 millionTranscript
11/7/2019Q3($0.15)($0.19)($0.19)$28.02 million$21.92 millionN/A
8/6/2019Q2 2019($0.16)($0.16)($0.16)$22.27 million$24.62 millionN/A
5/3/2019Q1 2019($0.17)($0.20)($0.20)$21.83 million$16.43 millionN/A
2/11/2019Q4 2018($0.1340)($0.21)($0.21)$21.08 million$19.53 millionN/A
11/1/20189/30/2018($0.15)($0.19)($0.19)$22.39 million$18.16 millionN/A
8/2/2018Q2 2018($0.17)($0.17)($0.17)$24.45 million$21.58 millionN/A
5/2/2018Q1 2018($0.19)($0.20)($0.20)$23.97 million$19.40 millionTranscript
2/1/2018Q4 2017($0.1960)($0.18)($0.18)$21.89 million$24.94 millionTranscript
11/2/2017Q3 2017($0.20)($0.19)($0.19)$28.29 million$23.54 millionN/A
8/2/2017Q2 2017($0.24)($0.26)($0.26)$23.34 million$20.07 millionListen
4/26/2017Q1 2017($0.23)($0.26)($0.26)$23.80 million$24.90 millionN/A
2/2/2017Q4 2016($0.23)($0.21)($0.21)$22.84 million$25.70 millionListen
11/2/2016Q3 2016($0.20)($0.19)($0.19)$24.68 million$25.10 millionN/A
8/4/2016Q2 2016($0.22)($0.21)($0.21)$20.19 million$20.70 millionN/A
4/21/2016Q1 2016($0.24)($0.23)($0.23)$18.02 million$19.10 millionListen
2/3/2016Q4 2015($0.02)($0.02)($0.02)$36.96 million$36.28 millionN/A
10/22/2015Q3 2015($0.27)($0.27)($0.56)$15.84 million$13.90 millionListen
8/5/2015Q2 2015($0.14)($0.16)($0.16)$26.36 million$24.94 millionListen
5/5/2015Q1 2015($0.27)($0.27)($0.27)$13.70 million$17.65 millionN/A
2/3/2015Q4 2014($0.26)($0.26)($0.26)$14.90 million$16.90 millionListen
10/23/2014Q3 2014($0.19)($0.13)($0.13)$17.20 million$20.60 millionListen
7/24/2014Q2 2014($0.28)($0.27)($0.27)$11.39 million$11.40 millionN/A
4/30/2014Q1 2014($0.28)($0.28)($0.28)$10.17 million$11.64 millionN/A
2/4/2014Q4 2013($0.28)($0.26)($0.26)$9.13 million$9.10 millionListen
10/22/2013Q3 2013($0.28)($0.31)($0.31)$7.08 million$7.40 millionN/A
8/1/2013Q2 2013($0.35)($0.33)($0.33)$6.09 million$6.04 millionN/A
4/23/2013Q1 2013($0.36)($0.37)($0.37)$4.28 million$5.60 millionN/A
2/5/2013Q4 2012($0.37)($0.39)$4.38 million$5.90 millionListen
10/27/2011Q3 2011($0.60)($0.45)($0.36)N/A
11/30/2010Q3 2010($39.70)($39.70)N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 2/25/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.